Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other solid neoplasm 1Lymphoid 1Genitourinary 1CNS 1

Conditions

Sarcoma 2Wilms Tumor 1Retinoblastoma 1Recurrence 1Osteosarcoma 1Optic Nerve Glioma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroblastoma 1Medulloblastoma 1Gastrointestinal Stromal Tumors 1Familial ependymoma 1Dendritic Cell Sarcoma, Interdigitating 1Burkitt Lymphoma 1Astrocytoma 1

Interventions

Filgrastim 6Carboplatin 5Temozolomide 4Irinotecan 3Ifosfamide 3Granulocyte Colony-Stimulating Factor 3Etoposide 3Busulfan 3Topotecan 2Radiotherapy 2Peripheral Blood Stem Cell Transplantation 2Oxaliplatin 2Melphalan 2Magnetic Resonance Spectroscopy 2Cyproheptadine 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2trioctyl phosphine oxide 1sargramostim 1ixabepilone 1ispinesib 1imetelstat 1gallium Ga 68 dotatate 1fluorodopa F 18 1exatecan 1etoposide phosphate 1becatecarin 1alvocidib 1Vorinostat 1Vincristine 1Verteporfin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Optic Nerve Glioma × alvocidib × Sarcoma × Clear all
NCT00012181 2013-07-02

Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas

National Cancer Institute (NCI)

Phase 1 Completed
30 enrolled
CNSGenitourinaryLymphoidOther solid neoplasmSarcoma

Familial ependymoma, Astrocytoma, Burkitt Lymphoma, Medulloblastoma, Wilms Tumor, Neuroblastoma, Recurrence, Retinoblastoma, Osteosarcoma, Neuroectodermal Tumors, Primitive, Peripheral, Optic Nerve Glioma, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡